HTG Molecular Diagnostics Inc (HTGM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
32
About the Report
About the Report
Summary
HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.
HTG Molecular Diagnostics Inc (HTGM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
HTG Molecular Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 11
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 12
HTG Molecular Diagnostics Raises USD 7.5 Million In Series E Financing 13
Partnerships 14
HTG Molecular Diagnostics Enters into Partnership Agreement with Oncologie 14
HTG Molecular Diagnostics and Firalis Enter into Agreement 15
HTG Molecular Diagnostics Inc-Key Competitors 16
HTG Molecular Diagnostics Inc-Key Employees 17
HTG Molecular Diagnostics Inc-Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
Aug 07, 2018: HTG Molecular Diagnostics reports second quarter 2018 results 19
May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results 20
Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results 21
Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance 22
Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings 23
Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 24
May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results 25
Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results 26
Corporate Communications 27
Oct 31, 2018: HTG Molecular appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President 27
Aug 16, 2018: HTG Molecular appoints Michelle R. Griffin to its board of directors 28
Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer 29
Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors 30
Legal and Regulatory 31
Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Figure
List of Figures
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Devices Deals, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 11
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 12
HTG Molecular Diagnostics Raises USD 7.5 Million In Series E Financing 13
HTG Molecular Diagnostics Enters into Partnership Agreement with Oncologie 14
HTG Molecular Diagnostics and Firalis Enter into Agreement 15
HTG Molecular Diagnostics Inc, Key Competitors 16
HTG Molecular Diagnostics Inc, Key Employees 17
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.